Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9493419 Quinoline derivatives as anti-cancer agents

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
December 22, 2011
0
Date of Patent
November 15, 2016
0
Patent Application Number
13334073
0
Patent Citations Received
‌
US Patent 12084430 Tricyclic urea compounds as JAK2 V617F inhibitors
0
‌
US Patent 11661422 Tricyclic urea compounds as JAK2 V617F inhibitors
0
‌
US Patent 11691971 Naphthyridinone compounds as JAK2 V617F inhibitors
0
‌
US Patent 11753413 Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors
‌
US Patent 11767323 Tricyclic pyridone compounds as JAK2 V617F inhibitors
‌
US Patent 11780840 Tricyclic urea compounds as JAK2 V617F inhibitors
‌
US Patent 11919908 Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
0
‌
US Patent 11958861 Spirocyclic lactams as JAK2 V617F inhibitors
0
Patent Inventor Names
Kim Hung Lam
0
Johnny Cheuk-on Tang
0
Sau Hing Chan
0
Albert Sun Chi Chan
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9493419
0
Patent Primary Examiner
‌
Timothy R Rozof
0

Find more entities like US Patent 9493419 Quinoline derivatives as anti-cancer agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo